Sanders Steven Andrew 4

What Happened

• Steven Andrew Sanders, a director of Avalon GloboCare Corp. (ALBT), received an award of derivative securities covering 200,000 shares on 2026-06-29. The reported price is $0.00 (no cash was paid at grant). The award is reported as a derivative transaction (code A) and the filing indicates 100% of the shares vested in full on the grant date (see footnote).

Key Details

• Transaction date: 2026-06-29
• Filing date: 2026-07-13 (Form 4); this appears to be filed late (more than the usual two business days after the transaction)
• Shares/derivatives acquired: 200,000
• Reported price: $0.00 (no cash consideration reported); economic value not stated on the Form 4
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: "One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date."
• Transaction code: A (grant/award/other acquisition); derivative securities reported

Context

• This was an equity award (derivative grant) as part of compensation — not an open-market purchase or sale. Because the award vested immediately, the director received full rights to the underlying shares/units, though conversion or settlement rules may still apply. Awards are routine compensation events and do not, by themselves, indicate personal buying or selling intent; subsequent Form 4s would show any later sales or exercises. The late filing reduces the timeliness of this disclosure for investors.